Biotech Stocks, Once Booming, Enter Bear Territory
Biotech companies are having one of their worst stock-market runs in years, as rising interest rates, scientific setbacks and a...
CVAC
CureVac Shares Plunge Premarket on Disappointing Covid-19 Vaccine Trial
Shares in Germany’s CureVac CVAC -3.47% NV fell by almost half in premarket trading, pointing to hefty losses for investors...
